Fairmount Funds Management LLC
Q3 2025 13F Holdings
- Locationwest conshohocken, PA
- Num holdings
17
- Value ($000)
$1,111,423
- Date Filed11/14/2025
- Form type13F-HR
- CIK0001802528
- All SEC filings
- NoteHoldings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q3 2025 toSelect Quarter
Issuer Name | Class | CUSIP | VALUE | % | Shares | Principal | Option Type |
|---|---|---|---|---|---|---|---|
DNTH DIANTHUS THERAPEUTICS INC | COM | 252828108 | $130.14 M | 12 % | 3,307,191 | ||
COGT COGENT BIOSCIENCES INC | COM | 19240Q201 | $129.29 M | 12 % | 9,003,418 | ||
AXSM AXSOME THERAPEUTICS INC | COM | 05464T104 | $99.00 M | 9 % | 815,176 | ||
APGE APOGEE THERAPEUTICS INC | COM | 03770N101 | $81.39 M | 7 % | 2,048,647 | ||
ELVN ENLIVEN THERAPEUTICS INC | COM | 29337E102 | $75.97 M | 7 % | 3,711,444 | ||
VRDN VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | $74.66 M | 7 % | 3,459,913 | ||
ORUKA THERAPEUTICS INC | COM | 687604108 | $71.25 M | 6 % | 3,705,262 | ||
KINIKSA PHARMACEUTICALS INTL | ORD SHS CL A | G52694109 | $68.84 M | 6 % | 1,772,839 | ||
SRRK SCHOLAR ROCK HLDG CORP | COM | 80706P103 | $67.93 M | 6 % | 1,824,031 | ||
SYRE SPYRE THERAPEUTICS INC | COM NEW | 00773J202 | $67.34 M | 6 % | 4,018,101 |
Rows Per Page
10
- 10
- 50
- 100